Finance

Lists
OM:NASDAQ
Outset Medical Inc
3,31 USD
-4,61%
(-0,16) 1D
3,31 USD
0,00% (0,00)
After hours
Closed: 9-сен., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OM...
Open
3,44 USD
High
3,52 USD
Low
3,30 USD
Mkt. cap
62,22 млн
Avg. vol.
133,67 миң
Volume
0,00
52-wk high
16,16 USD
52-wk low
3,00 USD
EPS
-4,08 USD
Beta
1,91
Shares outstanding
18,80 млн
No. of employees
310
Open
3,44 USD
High
3,52 USD
Low
3,30 USD
Mkt. cap
62,22 млн
Avg. vol.
133,67 миң
Volume
0,00
52-wk high
16,16 USD
52-wk low
3,00 USD
EPS
-4,08 USD
Beta
1,91
Shares outstanding
18,80 млн
No. of employees
310
About Outset Medical Inc
CEO-
Employees310
Founded2003
HeadquartersСан-Хосе, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to OM in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for OM in the last 3 months.
Highest
Current 3,31 USD
10,00 USD (+202,11%)
Average
7,67 USD (+131,72%)
Lowest
6,00 USD (+81,27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Rick Wise
Stifel Nicolaus
Buy
Reiterated
6,00 USD
+81,3%
08/07/2026
Kendall Au
RBC Capital
Hold
Maintained
7,00 USD
+111,5%
08/06/2026
Shagun Singh Chadha
RBC Capital
Hold
Maintained
7,00 USD
+111,5%
08/06/2026
Josh Jennings
TD Cowen
Buy
Reiterated
10,00 USD
+202,1%
08/07/2026
William Katz
TD Cowen
Buy
Reiterated
12,00 USD
+262,5%
04/07/2026
Marie Thibault
BTIG
Buy
Maintained
15,00 USD
+353,2%
02/18/2026
Last report
2026-ж., 6-авг.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,80 USD / -0,68 USD
-17,65%miss
Revenue / Est. (USD)
31,64 млн / 28,80 млн
+9,84%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
29,43 млн
28,87 млн
27,86 млн
31,64 млн
Cost of goods sold
17,84 млн
16,64 млн
15,77 млн
18,35 млн
Cost of revenue
17,84 млн
16,64 млн
15,77 млн
18,35 млн
Research and development expenses
5,38 млн
5,06 млн
5,62 млн
5,45 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22,03 млн
24,80 млн
23,40 млн
23,51 млн
Operating expense
27,40 млн
29,86 млн
29,01 млн
28,96 млн
Total operating expenses
45,24 млн
46,50 млн
44,78 млн
47,31 млн
Operating income
-15,81 млн
-17,63 млн
-16,92 млн
-15,68 млн
Other non operating income
-
-
-
-
EBT including unusual items
-17,43 млн
-19,40 млн
-18,76 млн
-17,76 млн
EBT excluding unusual items
-17,43 млн
-19,40 млн
-18,76 млн
-17,76 млн
Income tax expense
404,00 миң
95,00 миң
217,00 миң
220,00 миң
Effective tax rate
-2,32%
-0,49%
-1,16%
-1,24%
Other operating expenses
-
-
-
-
Net income
-17,84 млн
-19,49 млн
-18,98 млн
-17,98 млн
Net profit margin
-60,61%
-67,50%
-68,11%
-56,85%
Earnings per share
-0,69
-0,84
-0,83
-0,80
Interest and investment income
1,86 млн
1,67 млн
1,53 млн
1,35 млн
Interest expense
-3,48 млн
-3,44 млн
-3,37 млн
-3,44 млн
Net interest expenses
-1,62 млн
-1,77 млн
-1,84 млн
-2,09 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,80 млн
-16,75 млн
-16,12 млн
-15,05 млн
Gain or loss from assets sale
3,00 миң
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору